The P300 event-related potential and smoking - A population-based case-control study

International Journal of Psychophysiology

Volumn 77, Issue 2, 2010, Pages 166-175

  Mobascher, A ^a,b,c   Brinkmeyer, J ^a,b   Warbrick, T ^a,b   Wels, C ^a   Wagner, M ^d   Grunder G ^e   Spreckelmeyer, K N ^e   Wienker, T ^d   Diaz Lacava, A ^d   Dahmen, N ^c   Bottcher M ^f   Thuerauf, N ^g   Clepce, M ^g   Kiefer, F ^h   De Millas, W ⁱ   Gallinat, J ⁱ   Winterer, G ^b,j  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Helmholtz Research Center Juelich   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f Arztpraxis fur Medizinische Mikrobiologie und Labordiagnostik   (Germany)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

Cognition; EEG; Nicotine; P300; Smoking

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG ABUSE; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; SMOKING; TOBACCO DEPENDENCE;

ADULT; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SMOKING; YOUNG ADULT;

EID: 77954386404     PISSN: 01678760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpsycho.2010.06.002     Document Type: Article

References (61)

1. Agrawal A., Pergadia M.L., Balasubramanian S., Saccone S.F., Hinrichs A.L., Saccone N.L., Breslau N., Johnson E.O., Hatsukami D., Martin N.G., Montgomery G.W., Goate A.M., Rice J.P., Bierut L.J., Madden P.A. Further evidence for an association between the gamma-aminobutyric acid receptor A, subunit 4 gene on chromosome 4 and Fagerström test for nicotine dependence. Addiction 2009, 104:471-477.
2. Anokhin A.P., Vedeniapin A.B., Sirevaag E.J., Bauer L.O., O'Connor S.J., Kuperman S., Porjesz B., Reich T., Begleiter H., Polich J., Rohrbaugh J.W. The P300 brain potential is reduced in smokers. Psychopharmacology (Berl) 2000, 149:409-413.
3. Baudena P., Halgren E., Heit G., Clarke J.M. Intracerebral potentials to rare target and distractor auditory and visual stimuli. III. Frontal cortex. Electroencephalogr. Clin. Neurophysiol. 1995, 94:251-264.
4. Begleiter H., Porjesz B., Bihari B., Kissin B. Event-related brain potentials in boys at risk for alcoholism. Science 1984, 225:1493-1496.
5. Benowitz N.L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin. Pharmacol. Ther. 2008, 83:531-541.
6. Bierut L.J., Stitzel J.A., Wang J.C., Hinrichs A.L., Grucza R.A., Xuei X., Saccone N.L., Saccone S.F., Bertelsen S., Fox L., Horton W.J., Breslau N., Budde J., Cloninger C.R., Dick D.M., Foroud T., Hatsukami D., Hesselbrock V., Johnson E.O., Kramer J., Kuperman S., Madden P.A., Mayo K., Nurnberger J., Pomerleau O., Porjesz B., Reyes O., Schuckit M., Swan G., Tischfield J.A., Edenberg H.J., Rice J.P., Goate A.M. Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry 2008, 165:1163-1171.
7. Cohen H.L., Ji J., Chorlian D.B., Begleiter H., Porjesz B. Alcohol-related ERP changes recorded from different modalities: a topographic analysis. Alcohol. Clin. Exp. Res. 2002, 26:303-317.
8. Domino E.F., Ni L. Clinical phenotyping strategies in selection of tobacco smokers for future genotyping studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:1071-1078.
9. Duncan C.C., Kosmidis M.H., Mirskym A.F. Closed head injury-related information processing deficits: an event-related potential analysis. Int. J. Psychophysiol. 2005, 58:133-157.
10. Duncan C.C., Barry R.J., Connolly J.F., Fischer C., Michie P.T., Näätänen R., Polich J., Reinvang I., Van Petten C. Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin. Neurophysiol. 2009, 120:1883-1908.
11. Evans D.E., Drobes D.J. Nicotine self-medication of cognitive-attentional processing. Addict. Biol. 2009, 14:32-42.
12. Fagerström K., Furberg H. A comparison of the Fagerström test for nicotine dependence and smoking prevalence across countries. Addiction 2008, 103:841-845.
13. Goodin D.S., Aminoff M.J. Electrophysiological differences between subtypes of dementia. Brain 1986, 109:1103-1113.
14. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 60:636-645.
15. Guney F., Genc B.O., Kutlu R., Ilhan B.C. Auditory P300 event-related potential in tobacco smokers. J. Clin. Neurosci. 2009, 16:1311-1315.
16. Halgren E., Baudena P., Clarke J.M., Heit G., Liégeois C., Chauvel P., Musolino A. Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe. Electroencephalogr. Clin. Neurophysiol. 1995, 94:191-220.
17. Halgren E., Baudena P., Clarke J.M., Heit G., Marinkovic K., Devaux B., Vignal J.-P., Biraben A. Intracerebral potentials to rare target and distractor auditory and visual stimuli. II. Medial, lateral and posterior temporal lobe. Electroencephalogr. Clin. Neurophysiol. 1995, 94:229-250.
18. Hall M.H., Rijsdijk F., Picchioni M., Schulze K., Ettinger U., Toulopoulou T., Bramon E., Murray R.M., Sham P. Substantial shared genetic influences on schizophrenia and event-related potentials. Am. J. Psychiatry 2007, 164:804-812.
19. Hansenne M. The p300 cognitive event-related potential II. Individual variability and clinical application in psychopathology. Neurophysiol. Clin. 2000, 30:211-231.
20. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
21. Hoffman L.D., Polich J. P300, handedness, and corpus callosum size: gender, modality, and task. Int. J. Psychophysiol. 1999, 31:163-174.
22. Holmes A.P., Blair R.C., Watson J.D., Ford I. Nonparametric analysis of statistical images from functional mapping experiments. J. Cereb. Blood Flow Metab. 1996, 16:7-12.
23. Houlihan M.E., Pritchard W.S., Robinson J.H. Faster P300 latency after smoking in visual but not auditory oddball tasks. Psychopharmacolgy (Berl) 1996, 123:231-238.
24. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., Mukeria A., Szeszenia-Dabrowska N., Lissowska J., Rudnai P., Fabianova E., Mates D., Bencko V., Foretova L., Janout V., Chen C., Goodman G., Field J.K., Liloglou T., Xinarianos G., Cassidy A., McLaughlin J., Liu G., Narod S., Krokan H.E., Skorpen F., Elvestad M.B., Hveem K., Vatten L., Linseisen J., Clavel-Chapelon F., Vineis P., Bueno-de-Mesquita H.B., Lund E., Martinez C., Bingham S., Rasmuson T., Hainaut P., Riboli E., Ahrens W., Benhamou S., Lagiou P., Trichopoulos D., Holcátová I., Merletti F., Kjaerheim K., Agudo A., Macfarlane G., Talamini R., Simonato L., Lowry R., Conway D.I., Znaor A., Healy C., Zelenika D., Boland A., Delepine M., Foglio M., Lechner D., Matsuda F., Blanche H., Gut I., Heath S., Lathrop M., Brennan P. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452:633-637.
25. Iacono W.G., Carlson S.R., Malone S.M., McGue M. P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys. Arch. Gen. Psychiatry 2002, 59:750-757.
26. Iacono W.G., Malone S.M., McGue M. Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude. Int. J. Psychophysiol. 2003, 48:147-178.
27. Janson H. Longitudinal patterns of tobacco smoking from childhood to middle age. Addict. Behav. 1999, 24:239-249.
28. Joseph A.M., Hecht S.S., Murphy S.E., Carmella S.G., Le C.T., Zhang Y., Han S., Hatsukami D.K. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol. Biomark. Prev. 2005, 14:2963-2968.
29. Khokhar J.Y., Ferguson C.S., Zhu A.Z.X., Tyndale R.F. Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. Annu. Rev. Pharmacol. Toxicol. 2010, 50:39-61.
30. Knott V., Bosman M., Mahoney C., Ilivitsky V., Quirt K. Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials. Pharmacol. Biochem. Behav. 1999, 63:253-261.
31. Kügler C.F., Taghavy A., Platt D. The event-related P300 potential analysis of cognitive human brain aging: a review. Gerontology 1993, 39:280-303.
32. Lehmann D., Skrandies W. Reference-free identification of components of checkerboard-evoked multichannel potential fields. Electroencephalogr. Clin. Neurophysiol. 1980, 48:609-621.
33. Levin E.D., McCleron F.J., Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localization. Psychopharmacology (Berl) 2006, 184:523-593.
34. Li M.D., Cheng R., Ma J.Z., Swan G.E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003, 98:23-31.
35. Lindgren M., Molander L., Verbaan C., Lunell E., Rosén I. Electroencephalographic effects of intravenous nicotine - a dose-response study. Psychopharmacology (Berl) 1999, 145:342-350.
36. Mobascher A., Winterer G. The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry 2008, 41(Suppl 1):S51-S59.
37. Neuhaus A., Bajbouj M., Kienast T., Kalus P., von Haebler D., Winterer G., Gallinat J. Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacolgy (Berl) 2006, 186:191-200.
38. O'Donnell B.F., Vohs J.L., Hetrick W.P., Carroll C.A., Shekhar A. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. Int. J. Psychophysiol. 2004, 53:45-55.
39. Pascual-Marqui R.D. Review of methods for solving the EEG inverse problem. Int. J. Bioelectromagnetism 1999, 1:75-86.
40. Pascual-Marqui R.D. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Meth. Find. Exp. Clin. Pharmacol. 2002, 24(Suppl. D):5-12.
41. Pascual-Marqui R.D., Michel C.M., Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int. J. Psychophysiol. 1994, 18:49-65.
42. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophysiol. 2007, 118:2128-2148.
43. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. Int. J. Psychophysiol. 2006, 60:172-185.
44. Polich J., Ochoa C.J. Alcoholism risk, tobacco smoking, and P300 event-related potential. Clin. Neurophysiol. 2004, 115:1374-1383.
45. Pritchard W., Sokhadze E., Houlihan M. Effects of nicotine and smoking on event-related potentials: a review. Nicotine Tob. Res. 2004, 6:961-984.
46. Ramachandran G., Porjesz B., Begleiter H., Litke A. A simple auditory oddball task in young male adults at high risk for alcoholism. Alcohol. Clin. Exp. Res. 1996, 20:9-15.
47. Russo P.M., De Pascalis V., Varriale V., Barratt E.S. Impulsivity, intelligence and P300 wave: an empirical study. Int. J. Psychophysiol. 2008, 69:112-118.
48. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the alcohol use disorder identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction 1993, 88:791-804.
49. Singh S.M., Basu D. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a review. Addict. Biol. 2009, 14:298-309.
50. Skrandies W. Global field power and topographic similarity. Brain Topogr. 1990, 3:137-141.
51. Steffensen S.C., Ohran A.J., Shipp D.N., Hales K., Stobbs S.H., Fleming D.E. Gender-selective effects of the P300 and N400 components of the visual evoked potential. Vis. Res. 2008, 48:917-925.
52. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., Stacey S.N., Bergthorsson J.T., Thorlacius S., Gudmundsson J., Jonsson T., Jakobsdottir M., Saemundsdottir J., Olafsdottir O., Gudmundsson L.J., Bjornsdottir G., Kristjansson K., Skuladottir H., Isaksson H.J., Gudbjartsson T., Jones G.T., Mueller T., Gottsäter A., Flex A., Aben K.K., de Vegt F., Mulders P.F., Isla D., Vidal M.J., Asin L., Saez B., Murillo L., Blondal T., Kolbeinsson H., Stefansson J.G., Hansdottir I., Runarsdottir V., Pola R., Lindblad B., van Rij A.M., Dieplinger B., Haltmayer M., Mayordomo J.I., Kiemeney L.A., Matthiasson S.E., Oskarsson H., Tyrfingsson T., Gudbjartsson D.F., Gulcher J.R., Jonsson S., Thorsteinsdottir U., Kong A., Stefansson K. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-641.
53. Tiffany S.T., Drobes D.J. The development and initial validation of a questionnaire on smoking urges. Br. J. Addict. 1991, 86:1467-1476.
54. Towle V.L., Bolanos J., Suarez D., Tan K., Grzeszcuk R., Levin D.N., Cakmur R., Frank S.A., Spire J.-P. The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy. Electroenceph. Clin. Neurosci. 1993, 86:1-6.
55. van Beisterveldt C.E.M., Boomsma D.I. Genetics of the human electroencephalogram (EEG) and event-related potentials (ERPs): a review. Hum. Genet. 1994, 94:319-330.
56. van Beisterveldt C.E.M., van Baal G.C.M. Twin and family studies of the human electroencephalogram: a review and meta-analysis. Biol. Psychol. 2002, 61:111-138.
57. Vink J.M., Willemsen G., Boomsma D.I. Heritability of smoking initiation and nicotine dependence. Behav. Genet. 2005, 35:397-406.
58. Vink J.M., Willemsen G., Beem L., Boomsma D.I. The Fagerström test for nicotine dependence in a Dutch sample of daily smokers and ex-smokers. Addict. Behav. 2005, 30:575-579.
59. Walhovd K.B., Rosquist H., Fiell A.M. P300 amplitude age reductions are not caused by latency jitter. Psychophysiology 2008, 45:545-553.
60. Winterer G., Egan M.F., Raedler T., Sanchez C., Jones D.W., Coppola R., Weinberger D.R. P300 and genetic risk for schizophrenia. Arch. Gen. Psychiatry 2003, 60:1158-1167.
61. Yoon H.H., Iacono W.G., Malone S.M., Mc Gue M. Using the brain P300 response to identify novel phenotypes reflecting genetic variability for adolescent substance misuse. Addict. Behav. 2006, 31:1067-1087.